Hitomi Matsukawa

Dr. Hitomi Matsukawa

Wakayama Medical University, Wakayama, Japan
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2020 in Cancers
Verified
Journal Article
Open access
PDF file
TNTomoko Noguchi
Tomoko Noguchi
NINaoyuki Iwahashi
Naoyuki Iwahashi
KSKazuko Sakai
Kazuko Sakai
KMKaho Matsuda
Kaho Matsuda
HMHitomi Matsukawa
Hitomi Matsukawa
KIKazuhiko Ino
Kazuhiko Ino
Liquid biopsies from circulating tumor DNA (ctDNA) have been employed recently as a non-invasive diagnostic tool for detecting cancer-specific gene mutations. Here, we show the comprehensive gene mutation profiles of ctDNA in 51 patients with different histological subtypes of stage I–IV ovarian cancer, and their association with clinical outcomes. The ctDNA extracted from pre-treatment patients’ plasma were analyzed using Cancer Personalized Profiling by Deep Sequencing targeting 197 genes. Of 51 patients, 48 (94%) showed one or more non-synonymous somatic mutations, including TP53 (37.3%), APC (17.6%), KRAS (15.7%), EGFR (13.7%), MET (11.8%), PIK3CA (11.8%), NPAP1 (11.8%), and ALK (9.8%). The most frequently mutated genes were as follows: TP53 in high-grade serous carcinoma (66.7%), APC in clear cell carcinoma (30.8%), PIK3CA in endometrioid carcinoma (40%), and KRAS in mucinous carcinoma (66.7%). Higher cell-free (cf)DNA concentration significantly correlated with worse progression-free survival (PFS) in all patients as well as stage III–IV patients (p = 0.01 and 0.005, respectively). Further, patients with any pathogenic mutations showed significantly worse PFS (p = 0.048). Blood tumor mutational burden detected from ctDNA did not significantly correlate with the histological subtypes or survival. Collectively, clinico-genomic profiles of individual ovarian cancer patients could be identified using ctDNA and may serve as a useful prognostic indicator. These findings suggest that ctDNA-based gene profiling might help in establishing personalized therapeutic strategies.

24 September 2021 in Molecular and Clinical Oncology
Verified
Journal Article
Open access
PDF file
YAYuki Anami
Yuki Anami
SMSawako Minami
Sawako Minami
AKAya Kumegawa
Aya Kumegawa
HMHitomi Matsukawa
Hitomi Matsukawa
KNKaho Nishioka
Kaho Nishioka
KIKazuhiko Ino
Kazuhiko Ino
There have been very few reports on the use of immune checkpoint inhibitors for malignant tumors during pregnancy. Herein, the current study reports a case of a patient diagnosed with advanced malignant melanoma who was treated with pembrolizumab during pregnancy. A 40‑year‑old primigravida underwent noninvasive prenatal testing at 10 weeks of gestation, and the result was inconclusive, suggesting the possibility of maternal malignancy. A biopsy of the gluteal mass led to a diagnosis of malignant melanoma, and computed tomography revealed extensive metastases in her lungs and lymph nodes. She had a strong desire to proceed with pregnancy. In consideration of fetal growth and maturation, monotherapy was administered with pembrolizumab from 21 weeks of gestation, aiming for 28 weeks of gestation. The fetus grew well without maternal complications. At 28 weeks of pregnancy, the patient gave birth to a healthy boy by cesarean section. There was no evidence of metastasis in the placenta. The patient received nivolumab‑ipilimumab combination therapy from postpartum day 13, followed by nivolumab monotherapy, and has been alive with controlled disease for 20 months.

20 September 2021 in Molecular and Clinical Oncology
Verified
Journal Article
Open access
PDF file
HMHitomi Matsukawa
Hitomi Matsukawa
NONami Ota
Nami Ota
KNKaho Nishioka
Kaho Nishioka
TNTomoko Noguchi
Tomoko Noguchi
NINaoyuki Iwahashi
Naoyuki Iwahashi
KIKazuhiko Ino
Kazuhiko Ino
Low‑grade endometrial stromal sarcoma (LG‑ESS) is a rare tumor that mostly occurs in perimenopausal women. Treatment with total hysterectomy and bilateral salpingo‑oophorectomy is recommended, although fertility preservation or ovarian preservation may be considered in younger patients. The present study reports a case of LG‑ESS in a young woman diagnosed after resection of endometrial polyp‑like lesions. A 26‑year‑old nulligravid woman was referred to our hospital after being diagnosed with endometrial polyps. Hysteroscopic endometrial polypectomy was performed twice, and LG‑ESS was suspected on postoperative pathological examination. Magnetic resonance imaging revealed a tumor 5‑cm in diameter on the right side of the uterus. In light of the young age of the patient, tumorectomy was first performed, and postoperative pathological diagnosis was LG‑ESS with the positive resection margin. After thorough discussion with the patient about fertility preservation and recurrence risk, a total abdominal hysterectomy and ovarian preservation was performed. Medroxyprogesterone therapy was performed postoperatively and no recurrence was observed for 2 years.

28 July 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
HMHitomi Matsukawa
Hitomi Matsukawa
MIMidori Ikezaki
Midori Ikezaki
KNKaho Nishioka
Kaho Nishioka
NINaoyuki Iwahashi
Naoyuki Iwahashi
MFMasakazu Fujimoto
Masakazu Fujimoto
KIKazuhiko Ino
Kazuhiko Ino
Calnexin (CNX), a membrane-bound molecular chaperone, is involved in protein folding and quality control of nascent glycoproteins in the endoplasmic reticulum. We previously suggested critical roles of calreticulin, a functional paralogue of CNX, in placentation, including invasion of extravillous trophoblasts and syncytialization of cytotrophoblasts. However, the roles of CNX in placentation are unclear. In human choriocarcinoma BeWo cells, which serve as an experimental model of syncytialization, CNX knockdown suppressed forskolin-induced cell fusion and β-human chorionic gonadotropin (β-hCG) induction. Cell-surface luteinizing hormone/chorionic gonadotropin receptor, a β-hCG receptor, was significantly down-regulated in CNX-knockdown cells, which suggested the presence of a dysfunctional autocrine loop of β-hCG up-regulation. In this study, we also found abundant CNX expression in normal human placentas. Collectively, our results revealed the critical role of CNX in the syncytialization-related signaling in a villous trophoblast model and suggest a link between CNX expression and placenta development.